High intensity focused ultrasound (HIFU) is a novel prostate cancer treatment that minimizes side effect while destroying ...
Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...
Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...
Incorporating biomarkers into standard practice enhances diagnostic accuracy, supporting confident treatment decisions and optimizing care.
Tissue-based genomic classifier tests, developed to improve prostate cancer risk assessment and treatment recommendations, ...
White button mushrooms promoted antitumor activity among men with prostate cancer, according to results of an ongoing ...
For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk ...
In 2024, Feng received the “Mentorship Award” from ASTRO. In December, the American Society for Clinical Oncology (ASCO) ...
A groundbreaking, hour-long procedure using electrical currents to eliminate hard-to-reach prostate tumors is providing ...